Atlas Arteria Limited
Atlas Arteria Limited (MAQAF) Stock Overview
Explore Atlas Arteria Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
5.1B
P/E Ratio
33.02
EPS (TTM)
$0.15
ROE
0.05%
MAQAF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Atlas Arteria Limited (MAQAF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $2.66.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 33.02 and a market capitalization of 5.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 13.4% interest in 22-kilometer toll road investors partnership II (TRIP II), the concessionaire for Dulles Greenway toll road located in Virginia, the United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia.
Hugh Wehby BEc DipInvRel
180 Flinders Street, Melbourne, VIC
2010